Perceiving SARS-CoV-2 Mpro and PLpro dual inhibitors from pool of recognized antiviral compounds of endophytic microbes: an in silico simulation study

Coronavirus disease 2019 (COVID-19) persists and shook the global population where the endgame to this pandemic is brought on by developing vaccines in record-breaking time. Nevertheless, these vaccines are far from perfect where their efficiency ranges from 65 to 90%; therefore, vaccines are not th...

Descripción completa

Detalles Bibliográficos
Autores principales: Prajapati, Jignesh, Patel, Rohit, Rao, Priyashi, Saraf, Meenu, Rawal, Rakesh, Goswami, Dweipayan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990578/
https://www.ncbi.nlm.nih.gov/pubmed/35431517
http://dx.doi.org/10.1007/s11224-022-01932-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990578/
https://www.ncbi.nlm.nih.gov/pubmed/35431517
http://dx.doi.org/10.1007/s11224-022-01932-0

Ejemplares similares